Cargando…
Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
BACKGROUND: Severe obesity is associated with important morbidity and increased mortality. The successes of lifestyle modifications and drug therapy have been partial and mostly unsustained in reducing obesity and its comorbidities. Bariatric surgery, particularly biliopancreatic diversion with duod...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC416487/ https://www.ncbi.nlm.nih.gov/pubmed/15113416 http://dx.doi.org/10.1186/1475-2840-3-5 |
_version_ | 1782121423220768768 |
---|---|
author | Woods, Philippe Paquette, Carmen Martin, Julie Dumesnil, Jean-Gaston Marceau, Picard Marceau, Simon Biron, Simon Hould, Frédéric Lescelleur, Odette Lebel, Stéphane Poirier, Paul |
author_facet | Woods, Philippe Paquette, Carmen Martin, Julie Dumesnil, Jean-Gaston Marceau, Picard Marceau, Simon Biron, Simon Hould, Frédéric Lescelleur, Odette Lebel, Stéphane Poirier, Paul |
author_sort | Woods, Philippe |
collection | PubMed |
description | BACKGROUND: Severe obesity is associated with important morbidity and increased mortality. The successes of lifestyle modifications and drug therapy have been partial and mostly unsustained in reducing obesity and its comorbidities. Bariatric surgery, particularly biliopancreatic diversion with duodenal switch reduces efficiently excess body weight and improves metabolic and cardiovascular functions. CASE PRESENTATION: A 56-year-old man with severe clinical obesity underwent a biliopancreatic diversion with a duodenal switch after unsuccessful treatment with weight loss pharmacotherapy. He had diabetes, hypertension and sleep apnea syndrome and was on three medications for hypertension and two hypoglycemic agents in addition to > 200 insulin units daily. Eleven months after the surgery, he had lost 40% of his body weight. The lipid profile showed great improvement and the hypertension and diabetes were more easily controlled with no more insulin needed. The pseudonormalized pattern of left ventricular diastolic function improved and ventricular walls showed decreased thickness. CONCLUSION: Biliopancreatic diversion may bring metabolic and cardiovascular benefits in severely obese patients from a cardiovascular perspective. |
format | Text |
id | pubmed-416487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-4164872004-05-23 Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient Woods, Philippe Paquette, Carmen Martin, Julie Dumesnil, Jean-Gaston Marceau, Picard Marceau, Simon Biron, Simon Hould, Frédéric Lescelleur, Odette Lebel, Stéphane Poirier, Paul Cardiovasc Diabetol Case Report BACKGROUND: Severe obesity is associated with important morbidity and increased mortality. The successes of lifestyle modifications and drug therapy have been partial and mostly unsustained in reducing obesity and its comorbidities. Bariatric surgery, particularly biliopancreatic diversion with duodenal switch reduces efficiently excess body weight and improves metabolic and cardiovascular functions. CASE PRESENTATION: A 56-year-old man with severe clinical obesity underwent a biliopancreatic diversion with a duodenal switch after unsuccessful treatment with weight loss pharmacotherapy. He had diabetes, hypertension and sleep apnea syndrome and was on three medications for hypertension and two hypoglycemic agents in addition to > 200 insulin units daily. Eleven months after the surgery, he had lost 40% of his body weight. The lipid profile showed great improvement and the hypertension and diabetes were more easily controlled with no more insulin needed. The pseudonormalized pattern of left ventricular diastolic function improved and ventricular walls showed decreased thickness. CONCLUSION: Biliopancreatic diversion may bring metabolic and cardiovascular benefits in severely obese patients from a cardiovascular perspective. BioMed Central 2004-04-27 /pmc/articles/PMC416487/ /pubmed/15113416 http://dx.doi.org/10.1186/1475-2840-3-5 Text en Copyright © 2004 Woods et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Case Report Woods, Philippe Paquette, Carmen Martin, Julie Dumesnil, Jean-Gaston Marceau, Picard Marceau, Simon Biron, Simon Hould, Frédéric Lescelleur, Odette Lebel, Stéphane Poirier, Paul Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient |
title | Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient |
title_full | Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient |
title_fullStr | Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient |
title_full_unstemmed | Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient |
title_short | Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient |
title_sort | metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC416487/ https://www.ncbi.nlm.nih.gov/pubmed/15113416 http://dx.doi.org/10.1186/1475-2840-3-5 |
work_keys_str_mv | AT woodsphilippe metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT paquettecarmen metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT martinjulie metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT dumesniljeangaston metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT marceaupicard metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT marceausimon metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT bironsimon metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT houldfrederic metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT lescelleurodette metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT lebelstephane metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient AT poirierpaul metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient |